As of 2024-12-12, the Intrinsic Value of Abbvie Inc (ABBV) is
123.04 USD. This Abbvie valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 174.37 USD, the upside of Abbvie Inc is
-29.40%.
The range of the Intrinsic Value is 71.32 - 289.43 USD
123.04 USD
Intrinsic Value
Abbvie Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
71.32 - 289.43 |
123.04 |
-29.4% |
| DCF (Growth 10y) |
98.30 - 347.62 |
157.77 |
-9.5% |
| DCF (EBITDA 5y) |
74.78 - 97.80 |
81.08 |
-53.5% |
| DCF (EBITDA 10y) |
100.02 - 135.53 |
111.77 |
-35.9% |
| Fair Value |
52.66 - 52.66 |
52.66 |
-69.80% |
| P/E |
71.77 - 160.77 |
121.94 |
-30.1% |
| EV/EBITDA |
96.77 - 232.53 |
171.15 |
-1.8% |
| EPV |
114.27 - 154.65 |
134.46 |
-22.9% |
| DDM - Stable |
32.29 - 112.53 |
72.41 |
-58.5% |
| DDM - Multi |
84.70 - 194.97 |
114.57 |
-34.3% |
Abbvie Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
308,136.20 |
| Beta |
0.23 |
| Outstanding shares (mil) |
1,767.14 |
| Enterprise Value (mil) |
371,958.20 |
| Market risk premium |
4.60% |
| Cost of Equity |
8.30% |
| Cost of Debt |
4.67% |
| WACC |
7.61% |